CIK 0001752828
- Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831702591
- Phone
- +1 908-768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- 4 Open-market buy Chief Executive Officer bought 40,000 shares at $1.74 ($69,600)
- 4 Shares withheld for taxes Chief Business Officer gave up 3,734 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel gave up 1,262 shares (to pay taxes)
- 4 Shares withheld for taxes Glover Bradley gave up 3,734 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion Director acquired 768,594 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 119,073 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 36,145 shares (grant or award)
- 4 Grant or award Director acquired 36,145 shares (grant or award)
- 4 Grant or award Director acquired 36,145 shares (grant or award)
- 4 Grant or award Director acquired 36,145 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 13,124 shares (grant or award)
- 4 Grant or award Director acquired 36,145 shares (grant or award)
- 4 Grant or award Director acquired 36,145 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 11,483 shares (grant or award)
- 4 Grant or award General Counsel acquired 2,297 shares (grant or award)
- 4 Grant or award Director acquired 36,145 shares (grant or award)
- 4 Grant or award Director acquired 36,145 shares (grant or award)
Page 6 of 10 · 191 filings